Enzymaster Completed Series B-1 Financing Round

Enzymaster, a global biotech company with locations in China, Germany and Singapore specialized in biocatalysis and enzyme engineering, announced the close of a US$ 7.5 Mio (CNY 50 Mio) Series B-1 funding. The money has been raised from the Chinese investment firms Weifang Zhongke Haichuang Equity Investment Partnership, Tibet Leimerious Venture Investment Partnership, and Caozhixing […]